Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance
University of Michigan · NCT02043457
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 15–75 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 3200
- US sites recruiting
- 1
- Study start
- August 2009
- Record last updated
- July 13, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The Investigational Weight Management Clinic now entitled the Weight Management Program at the University of Michigan was created to identify strategies that will result in cost-effective, long term weight management for overweight and obese individuals. The driving hypothesis of the clinic is that the 'one size fits all' philosophy is untenable with a complex disease such as obesity. The clinic will serve as a portal for patients to choose standard clinical care or to explore alternatives from a variety of clinical studies offered through the clinic. These studies will include further investigations into nutrition, the biological basis of weight and weight management and protocols using approved and experimental pharmaceuticals as well as technologies that aid in self-management of weight.
Being studied: phenotyping
Conditions: Obesity
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Obese males and females: age >20 years; Obese population defined as BMI > or = 27 kg/m2
- Lean population BMI \< 27 but > 17 kg/m2
- Able and willing to provide written informed consent for the trial
Exclusion Criteria
- Evidence of inherited disorders of lipid metabolism.
- History of Cancer within the last 5 years
- Human immunodeficiency virus (HIV) antibody positive.
- Patients with solid organ transplants.
- Participation in any other clinical trial within 90 days of entry into this trial.
- Pregnant or lactating females.
- Uncontrolled thyroid disease
- Unstable angina or NY heart association class II failure or above
- Gastrointestinal disease specifically GI motility disorders
- Unstable neuropsychiatric disease including major depression/anxiety, eating disorder such as binge eating, bulimia or anorexia
- End stage renal or hepatic disease
- Autoimmune disorders (e.g. SLE)
- Body weight fluctuation of more than 5 kg in the previous 3 months
- Prior bariatric surgery
- A history or current alcohol/substance abuse and change in smoking habits or cessation in the past 6 months.
- Women of childbearing age must use a reliable form of contraception.
- Any medical condition, which in the opinion of the investigator would make the patient unsuitable for recruitment, or could interfere with the patient participating in or completing the protocol.
- Unwilling or unable to consent for the study.
Recruiting US locations
University of Michigan
Ann Arbor, MI 48106
Site contact: Amy E Rothberg, MD, PhD · 734-647-5871 · arothber@med.umich.edu
Study contacts (from the official record)
- Amy E Rothberg, MD, PhD · 734-647-5871 · arothber@med.umich.edu
Similar studies in Michigan
All weight loss studies in Michigan →- RecruitingPhase 3
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Amgen
- Location
- Troy, MI + 51 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 3
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Novo Nordisk A/S
- Location
- Southfield, MI + 13 other US sites
- Eligibility basics
- Ages 10–18
- RecruitingPhase 2
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Alveus Therapeutics, Inc.
- Location
- Farmington Hills, MI + 19 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
The RESET System Pivotal Clinical Trial (Protocol Revision K)
Morphic Medical Inc.
- Location
- Ann Arbor, MI + 25 other US sites
- Eligibility basics
- Ages 22–65